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Insulin-like growth factor 1 receptor (IGF-1R) signaling regulates the activity and
phosphorylation of downstream kinases linked to inflammation, neurodevelopment,
aging and synaptic function. In addition to the control of Ca2+ currents, IGF-1R
signaling modulates the activity of calcium-calmodulin-dependent kinase 2 alpha
(CaMKIIα) and mitogen activated protein kinase (MAPK/ErK) through multiple signaling
pathways. These proteins (CaMKIIα and MAPK) regulate Ca2+ movement and long-term
potentiation (LTP). Since IGF-1R controls the synaptic activity of Ca2+, CaMKIIα
and MAPK signaling, the possible mechanism through which an age-dependent
change in IGF-1R can alter the synaptic expression and phosphorylation of these
proteins in aging needs to be investigated. In this study, we evaluated the
relationship between an age-dependent change in brain IGF-1R and phosphorylation
of CaMKIIα/MAPK. Furthermore, we elucidated possible mechanisms through which
dysregulated CaMKIIα/MAPK interaction may be linked to a change in neurotransmitter
processing and synaptic function. Male C57BL/6 VGAT-Venus mice at postnatal days
80 (P80), 365 and 730 were used to study age-related neural changes in two brain
regions associated with cognitive function: hippocampus and prefrontal cortex (PFC).
By means of high throughput confocal imaging and quantitative immunoblotting, we
evaluated the distribution and expression of IGF-1, IGF-1R, CaMKIIα, p-CaMKIIα,
MAPK and p-MAPK in whole brain lysate, hippocampus and cortex. Furthermore,
we compared protein expression patterns and regional changes at P80, P365 and
P730. Ultimately, we determined the relative phosphorylation pattern of CaMKIIα and
MAPK through quantification of neural p-CaMKIIα and p-MAPK/ErK, and IGF-1R
expression for P80, P365 and P730 brain samples. In addition to a change in synaptic
function, our results show a decrease in neural IGF-1/IGF-1R expression in whole
brain, hippocampus and cortex of aged mice. This was associated with a significant
upregulation of phosphorylated neural MAPK (p-MAPK) and decrease in total brain
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CaMKIIα (i.e., CaMKIIα and p-CaMKIIα) in the aged brain. Taken together, we showed
that brain aging is associated with a change in neural IGF-1/IGF-1R expression and may
be linked to a change in phosphorylation of synaptic kinases (CaMKIIα and MAPK) that
are involved in the modulation of LTP.
Keywords: IGF-1/IGF-1R, aging, CaMKIIα, MAPK/ErK, KCa2.2
INTRODUCTION
Brain aging has been implicated in the cause and progression
of disease conditions, characterized in part by memory deficits
(Reagh and Yassa, 2017; Seeley, 2017), notably in disorders
like Alzheimer’s disease (Heckman et al., 2017; Vemuri et al.,
2017; Caballero et al., 2018). One underlying cause of the
behavioral changes associated with normal or disease-related
aging is modifications to synaptic morphology and molecular
composition (Bertoni-Freddari et al., 1988, 1992, 1993), which
often lead to neuronal cell death, oxidative stress and cytoskeletal
defects, which are implicated in age-linked disorders (Wilson
et al., 2016, 2017; Pellegrini et al., 2017; Salvadores et al., 2017).
Neurotrophic factors and receptors have important roles
during development and in the adult brain. During development,
neural progenitor cells develop cytoskeletal structures (neurites)
required for cell migration in the developing brain (Chou and
Wang, 2016; Hanamura, 2017). In the absence of neurotrophic
factors, neuronal development is impaired (Sanford et al., 2008;
Park and Poo, 2013). Depending on the stage of development,
depletion of neurotrophins may halt neural cell migration and
formation of synapses in several brain circuits (Park and Poo,
2013; Chou and Wang, 2016). Therefore, the process of neural
circuit formation is a set of molecular events governed by
neurotrophic activation of neurotropin receptors (Mousa and
Bakhiet, 2013; Bertrand, 2017). Similarly, in the adult nervous
system, neurotrophic factors and receptors are required for
the maintenance of active synapses (Gómez-Palacio-Schjetnan
and Escobar, 2008; Ito-Ishida et al., 2008; Garcia et al., 2012;
Ivanov, 2014). There are several neurotropic factors in the
brain; insulin-like growth factor-1 (IGF-1), nerve growth factor
(NGF) and, brain derived neurotropic factor (BDNF) among
others (Yuen et al., 1996; Park and Poo, 2013; Song et al.,
2017; Zegarra-Valdivia, 2017), which have associated receptors,
such as Insulin-like growth factor 1 receptor (IGF-1R), IGF-1
receptor 2 (IGF-2R), and Tyrosine kinase receptors (RTkA and
RTkB; Mousa and Bakhiet, 2013; Dyer et al., 2016; Bertrand,
2017).
IGF-1 and IGF-1R are particularly important because of
their role in neurodevelopment, synaptic function and aging
(Bartke et al., 2003; Sonntag et al., 2005; Chiu and Cline, 2010;
Dyer et al., 2016). As such, changes in their expression pattern
have been implicated in the pathophysiology of developmental
and age-related neuropsychiatric disorders (Deak and Sonntag,
2012; Green et al., 2014; Dyer et al., 2016). In addition to their
involvement in formation of synapses, IGF-1 and IGF-1R act to
maintain synapses in the adult brain (Chiu and Cline, 2010; Gazit
et al., 2016; Nieto-Estévez et al., 2016; Decourtye et al., 2017;
Reim and Schmeisser, 2017). Notably, IGF-1/IGF-1R signaling
may alter the activity of proteins directly involved in synaptic
plasticity, cognitive and memory function (Bartke et al., 2003;
Sonntag et al., 2005; Deak and Sonntag, 2012).
The role of IGF-1—and other neurotropic factors such as
BDNF—in neuronal development and synaptic plasticity has
been described extensively (Nieto-Estévez et al., 2016; Reim and
Schmeisser, 2017). However, a recent study demonstrated that
IGF-1R is directly involved in the regulation of presynaptic
Ca2+ release during long-term potentiation (LTP) in the
hippocampus (Gazit et al., 2016). Therefore, both IGF-1 and
IGF-1R can directly modulate specific aspects of cognition
and memory function in the hippocampus (Sonntag et al.,
2005; Deak and Sonntag, 2012). IGF-1-mediated activation of
neurotropin receptors, and IGF-1R activation (by IGF-1 or
insulin) involves signaling of downstream proteins (Hiney et al.,
2009; Liu et al., 2015; Law et al., 2017). These kinases are
involved in several pathways associated with synaptic function,
growth, inflammation and metabolism (Schumacher et al., 1991;
Mynarcik et al., 1997; Siddle, 2011; Fernandez and Torres-
Alemán, 2012).
IGF-1 activation of insulin receptor or IGF-1R can initiate
Ras/ErK signaling (Lopaczynski, 1999; Moelling et al., 2002;
Dyer et al., 2016). Furthermore, Ras/Raf signaling can modulate
the phosphorylation of synaptic regulatory calcium-calmodulin-
dependent kinase 2 alpha (CaMKIIα; Villalonga et al., 2001;
Illario et al., 2003; Wu et al., 2011; DiBattista et al., 2015). Both
mitogen activated protein kinase (MAPK/ErK) and CaMKIIα
are likely colocalized at synaptic densities (Giovannini et al.,
2001; Tsui et al., 2005). As such, the phosphorylation status of
these proteins may alter hippocampal LTP and depression (LTD;
Giovannini et al., 2001; Derkach et al., 2007). Therefore, a change
in IGF-1/IGF-1R may affect synaptic function by altering the
balance between synaptic MAPK/ErK and CaMKIIα activity.
CaMKIIα and MAPK/ErK act downstream of IGF-1/IGF-1R
in various signaling pathways already described in neurons
(Chiu and Cline, 2010; Song et al., 2010; Zuloaga et al., 2013).
CaMKIIα controls LTP by regulating ionotropic receptors and
ion movement at post-synaptic densities (PSDs; Wang and Kelly,
2001; Hinds et al., 2003; Mao et al., 2014). Since MAPK/ErK
is co-localized with CaMKIIα at PSDs, it can alter the synaptic
activity of CaMKIIα by increased phosphorylation (Giovannini
et al., 2001; Tsui et al., 2005; Derkach et al., 2007). Physiologically,
the LTP process is associated with a synchronous oscillation of
Ca2+ and K+ ions (Bacci et al., 1999; Power et al., 2002; Allen
et al., 2011). During LTP, CaMKIIα increase Ca2+ currents from
inotropic glutamate receptor activation (Sanz-Clemente et al.,
2013; Mao et al., 2014; DiBattista et al., 2015) and inhibits small
ion conductance channels, such KCa2.2 (Hammond et al., 2006;
Lin et al., 2010; Griffith et al., 2016). Conversely, MAPK/ErK can
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inhibit CaMKIIα (Giovannini et al., 2001), while activating the
pore forming sub-units of calcium-activated potassium (KCa2.2)
channels (Schrader et al., 2006; Turner and Shieh, 2006).
KCa2.2 channels generates prolonged low-tone K+ currents
during LTP (Kim and Hoffman, 2008) and the hyperpolarization
phase of the action potential (Power et al., 2002; Hammond
et al., 2006; Lin et al., 2010). An increase in KCa2.2 activity
reduces the threshold of the action potential due to a sustained
after-hyperpolarization effect (Power et al., 2002; Stocker,
2004; Stocker et al., 2004; Lin et al., 2010). Thus, age-linked
neural changes, which promotes loss of CaMKIIα function, can
upregulate KCa2.2 activity through disinhibition of this channel.
Additionally, age-dependent increase in Ras/ErK activation
can promote KCa2.2 activity by attenuating (phosphorylating)
CaMKIIα-linked inhibition of KCa2.2. Furthermore, Ras-ErK
signaling can activate (phosphorylate) pore forming subunits of
KCa2.2.
Therefore, we asked whether an age-related change in
IGF-1/IGF-1R axis is related to changes in synaptic function
through age-related alterations of MAPK/ErK/CaMKIIα and
KCa2.2 in the hippocampus and PFC (Figure 1)? A decline in
IGF-1 and IGF-1R expression has been described in age-related
neuropsychiatric and degenerative diseases (Carro et al., 2002;
Yaghmaie et al., 2006; Piriz et al., 2011; Puche and Castilla-
Cortázar, 2012; Green et al., 2014; Werner and LeRoith, 2014).
Therefore, in this study we assessed the differential expression
of these synaptic kinases (i.e MAPK/ErK and CaMKIIα) with
age in the hippocampus and medial prefrontal cortex (mPFC).
Additionally, we examined the relationship between age-related
change in neural MAPK/ErK/CaMKIIα activity and expression
of synaptic markers—neurotransmitter transporters—in the
hippocampus (CA1) and mPFC.
MATERIALS AND METHODS
Animal Strain
Male C57BL/6 VGAT-Venus mice of the following age groups
were used for this study; postnatal days 80 (P80; young adult;
n = 11), P365 (middle aged; n = 10), P730 (elderly; n = 8).
The vesicular GABA transporter (VGAT) Venus mice have been
previously developed and characterized by Wang et al. (2009).
The animals (i.e., VGAT-Venus) used to establish the colony
for this study were obtained from Dr. Janice Nagle at Wesleyan
University and bred at the vivarium of the Louisiana State
University School of Veterinary Medicine. VGAT-Venus mice
are transgenic mice bred on a C57BL/6J background and carry no
mutations or abnormalities. These mice express a fluorescence
protein called Venus (a modified yellow fluorescence protein
developed by Atsushi Miyawaki at RIKEN, Wako, Japan) in
inhibitory GABAergic and Glycinergic neurons (Wang et al.,
2009). VGAT-Venus mice were used because it enables a
simple method for assaying changes in inhibitory neuronal
composition through immunofluorescence imaging (Lee et al.,
2015).
All animals used for this experiment weighed between
22–27 grams. Animals were kept under standard laboratory
conditions and handled in accordance to NIH guidelines for
animal care and use in research. All protocols used were
reviewed and approved by the Institutional Animal Care and
Use Committee of the Louisiana State University School of
Veterinary Medicine.
Sample Preparation
After the brains were collected, the right and left hemisphere were
used for immunofluorescence or immunoblotting preparations,
respectively.
Immunofluorescence
Animals were deeply anesthetized via inhalation of isoflurane
in an enclosed chamber, then perfused transcardially through
the left ventricle using 10 mM phosphate buffered saline (PBS).
The right half of the brain was collected and rapidly fixed in
4% PB paraformaldehyde (PFA) overnight at 4◦C. Subsequently,
the fixed brain samples were transferred into 4% PB-PFA
containing 30% sucrose for cryopreservation. Cryopreservation
was performed at 4◦C for 72 h. Free-floating cryostat sections (20
µm thick) were obtained using a Leica Cryostat and collected in
10 mM PBS at 4◦C. The sections were washed three times (5 min
each) in 10 mM PBS (pH 7.4) on a tissue rocker. Blocking was
done in normal goat serum (Vector Labs), prepared in 10 mM
PBS+0.03% Triton-X 100, for 2 h at room temperature. The
sections were incubated in primary antibody solution overnight
at 4◦C [Rabbit anti-IGF-1R (1:100; ThermoScientific-MA5-
15148), Mouse anti SK2.2 (EMD Millipore Q2650573; 1:250),
Rabbit anti-MAPK/ErK1/ErK2 (1:100; Cell Signaling-#9102) and
Mouse anti- CaMKIIα (1:100; Cell Signaling-#50049)]. The
primary antibodies were diluted appropriately in 10 mM PBS,
0.03% Triton-X 100 and normal goat serum. It is important
to note that VGAT-Venus mice express Venus in inhibitory
GABAergic and Glycinergic neurons: therefore, no staining was
necessary for Venus fluorescence observation. Subsequently, the
sections were washed as previously described and incubated
in secondary antibody solution [Goat anti Rabbit 568, Goat
anti Rabbit 594 and Goat anti Mouse 568 (diluted at 1:1000)
prepared in 10 mM PBS, 0.03% Triton X-100 and Normal Goat
Serum] at room temperature (1 h). Immunolabeled sections
were washed and mounted on gelatin-coated slides using a
plain or DAPI containing anti-fade mounting medium (Vector
Labs).
Confocal Microscopy
Imaging of immunolabeled proteins in the hippocampus and
cortex was performed by confocal microscopy (Olympus
FluoView 10i). Fluorescence intensity was estimated for
CaMKIIα, IGF-1R, MAPK/ErK and KCa2.2 using ImageJ
(Burgess et al., 2010; McCloy et al., 2014). In addition, cell
counting was conducted to determine the distribution of Venus-
expressing neurons per unit area in the hippocampus (CA1-
DG field) and mPFC (Layer V) using ImageJ (Grishagin, 2015).
Fluorescence quantification and cell counting was conducted in
n = 10 fields for n = 6 consecutive brain (serial) sections per
animal. The average fluorescence intensity and cell count was
determined and compared for all groups in One-Way analysis of
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FIGURE 1 | Schematic illustration of the mechanism through which calcium-calmodulin-dependent kinase 2 alpha (CaMKIIα) regulates long-term potentiation (LTP)
by modulating KCa2.2 and NMDAR function at post-synaptic densities (PSDs). Here, we show possible contributions of Insulin-like growth factor 1 receptor (IGF-1R;
1,2) signaling in the regulation of KCa2.2 and CaMKIIα. In normal synaptic function, CaMKIIα inhibits the conductance capability of KCa2.2 by blocking calcium
binding sites on its intracellular domain. Conversely, in long-term depression (LTD), CaMKIIα is phosphorylated and allows for conductance of K+ ions, thereby
obliterating synaptic potentials (3,4). In aging, we hypothesize that a change in IGF-1R signaling may reduce synaptic CaMKIIα function by upregulating mitogen
activated protein kinase (MAPK/ErK) activity. Thus, increased MAPK/ErK can hyperphosphorylate CaMKIIα (inactivate) and phosphorylate (activate) pore forming
subunits of KCa2.2.
variance (ANOVA) with Tukey post hoc test. Statistical analysis
was performed in GraphPad Prism Version 7.0.
Immunoblotting
The left whole brain was rapidly frozen and homogenized using
a low speed hand-held homogenizer. The brain homogenate
was centrifuged at 12,500 g for 15 min (4◦C) to isolate whole
brain lysate. Fifteen microgram of protein (3 biological replicates
for all samples), obtained from brain tissue homogenate,
was processed per well. After western blotting, protein was
detected using the following primary antibodies; Rabbit anti
IGF-1R (Cell Signaling-#3027s), Mouse anti-IGF-1 (abcam-
# ab176523), Rabbit anti-MAPK/ErK1/ErK2 (1:100; Cell
Signaling-#9102), Rabbit anti-phospho-MAPK/ErK1/ErK2 (Cell
Signaling-#4370s; sites: Thr202/Tyr204), Mouse anti-CaMKIIα
(Cell Signaling-#50049), Rabbit anti-phospho-CaMKIIα (Cell
Signaling-#12716s; site: Thr286), Mouse anti SK2.2 (EMD
Millipore-#Q2650573), Rabbit anti PSD-95 (Cell Signaling-
#3450s), Rabbit anti Homer-1 (Proteintech-#124-33-1-AP),
Rabbit anti Synaptophysin (Cell Signaling-#5461s), Rabbit anti
vesicular glutamate transporter 2 (VGLUT2; abcam-#ab84103),
Rabbit anti GAPDH (Cell Signaling-#5174s). Subsequently,
the primary antibodies were detected with HRP-conjugated
Goat anti Rabbit (Invitrogen #65-6120) and Goat anti Mouse
(Invitrogen #65-6520) secondary antibodies following which the
reaction was developed using a chemiluminescence substrate
(Thermofisher-#34579). Protein expression was quantified
and normalized with the housekeeping protein (GAPDH)
and synaptic proteins (PSD-95, Homer1 and Synaptophysin)
expression using Image Lab version 5.2.1 (BioRad, Hercules,
CA, USA). Multiple controls were used for normalizing each
protein of interest because of a general decline in neural proteins
with age (Carney et al., 1991; Schimanski and Barnes, 2010).
Subsequently, normalized protein expression data was analyzed
through One-Way ANOVA (with Tukey Post hoc test) in
GraphPad Prism Version 7.0. The outcome was presented as bar
chart with error bars representing the mean± SEM respectively.
STATISTICS
Analysis was conducted with the GraphPad Prism Version 7.0.
For the immunofluorescence results, the average fluorescence
intensity and cell count was determined and compared for all
groups in One-Way ANOVA with Tukey post hoc test. For
immunoblotting protein expression data, One-Way ANOVA
(with Tukey Post hoc test) was performed. The outcomes
are presented as bar chart with error bars representing the
mean± SEM respectively.
RESULTS
Changes in Control Protein Expression
With Age
We observed a significant decrease in expression level of
control proteins—GAPDH, PSD-95 and Homer1—in brain
lysate prepared from aged mice (P730) when compared
with P80 and P365 brain samples. This may have resulted
from age-related decrease in neural protein synthesis, or
loss of protein due to oxidation (Carney et al., 1991;
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Schimanski and Barnes, 2010). To ascertain an age-linked protein
depletion, equal volume (20 µl) and proteins concentration
(15 µg/well) were examined via Western blot for each sample
(animal) across all groups. As such, P730 mice exhibited a
significant decrease in MAPK, CaMKIIα, p-CaMKIIα, IGF-1
and IGF-1R. The results were normalized by the corresponding
expression of control proteins (GAPDH, Homer1, PSD-95
and synaptophysin) from the same sample in multiple trials.
Interestingly, control proteins—GAPDH, Homer1 and PSD-
95–were reduced significantly in P730 brain samples. Therefore,
band intensity for a protein of interest was divided by band
intensity for control proteins for the same sample. Ultimately,
the average expression after normalizing with various control
proteins was adopted as the normalized expression for the
protein. However, not all proteins were reduced in the aged brain.
Synaptophysin (a control) and p-MAPK/ErK were significantly
upregulated in P730 brain lysates when compared with P80 and
P365 samples. Therefore, a decrease in a control protein does not
connote a decrease in protein sample loaded for the P730 group.
Age-Dependent Change in Neural IGF-1
and IGF-1R Expression
First, we evaluated the distribution of IGF-1R in immunolabeled
brain sections containing the cortex and hippocampus. IGF-1R
expression was estimated through quantification of fluorescence
(see ‘‘Materials and Methods’’ section). For this procedure,
a constant exposure time and contrast was adopted for all
sections, relative to background staining. We observed an
age-dependent decrease in hippocampal IGF-1R expression
when P365 (p < 0.001) and P730 (p < 0.001) mice were
compared with their P80 counterparts (Figures 2A,C). In
addition, there was a significant reduction of IGF-1R staining
in the mPFC at P365 (p < 0.001) and P730 (p < 0.001) when
compared with the P80 mice (Figures 2B,D).
In quantitative immunoblotting of whole brain lysate,
there was an age-dependent decrease in neural IGF-1 level
when P730 mice were compared with P80 and P365 mice
(Figures 2E,F; p < 0.001). Interestingly, there was no significant
change in neural IGF-1 level at P365 when compared with P80
IGF-1 expression. Similar to the observations from confocal
quantification, there was a significant decrease (p < 0.001) in
IGF-1R expression with age in whole brain lysate of P365 and
P730 mice (Figures 2E,F). Furthermore, a significant decline
(p< 0.001) was observed when comparing P730with P365 neural
IGF-1R expression (Figures 2G,H). Based on these outcomes, we
deduced that a decline in both IGF-1 and IGF-1R are associated
with aging in the hippocampus and cortex. While IGF-1 decline
occurred later (P730) than IGF-1R depletion in the hippocampus
and cortex (P365). This outcome is based on the age ranges
adopted for this study. P80 expression was used as a baseline for
immunofluorescence and immunoblotting analysis.
Phosphorylation of Neural MAPK/ErK
Increased With Age
Using confocal imaging and quantification techniques, we
estimated and normalized the expression of MAPK/ErK
(fluorescence) in whole brain sagittal sections (Figure 3A).
In P365 vs. P80 mice, we recorded a significant increase in
prefrontal cortical and hippocampal MAPK/ErK expression
(Figure 3B; p < 0.001). At P730, MAPK/ErK expression varied
between the hippocampus and mPFC (Figure 3C). Hippocampal
MAPK/ErK expression increased at P730 when compared with
P365 (p < 0.001) and P80 (p < 0.001), but reduced significantly
in the mPFC when P730 mice were compared with P365
(Figure 3C; p < 0.001). However, mPFC MAPK/ErK expression
at P730 was higher than the baseline (vs. P80; p < 0.05).
Therefore, based on our hypothesis, a change in neural IGF-
1/IGF-1R expression may be associated with the region-specific
change in MAPK/ErK expression. As such, a reduction in
hippocampal and mPFC IGF-1R expression was accompanied by
an increase in MAPK/ErK.
Since MAPK/ErK is active in its phosphorylated form (Ferrer
et al., 2001; Hoofnagle et al., 2004), we compared the distribution
of MAPK/ErK and phosphorylated MAPK/ErK in whole
brain lysates from P80, P365 and P730 mice. Subsequently,
we determined the percentage phosphorylation of neural
MAPK/ErK by comparing GAPDH-normalized expression
of MAPK/ErK and p-MAPK/ErK in whole brain lysates [p-
MAPK/(p-MAPK+MAPK) × 100]. At P365, there was no
significant change in neural MAPK/ErK expression when
compared with P80 (baseline) MAPK/ErK expression
(Figures 3D,E). However, total brain MAPK/ErK expression
reduced significantly at P730 (Figures 3D,E; p < 0.001).
In subsequent analysis, we found age-related differences in
non-phosphorylated to phosphorylated forms of MAPK/ErK
(Figures 3F,G). As such, in P730 mice there was a significant
increase in p-MAPK/ErK in total brain lysate when compared
with P80 (p < 0.05) and P365 (p < 0.001). Based on these
outcomes, the percentage of normalized phosphorylated
MAPK/ErK was 85% for P730 mice when compared with P80
(47%) and P365 (25%; Figure 3H).
From these outcomes, we deduce that a change in IGF-
1/IGF-1R signaling may be linked with an increased conversion
of MAPK/ErK to p-MAPK/ErK in the brain of aged mice.
It is important to note that immunoblot outcomes for
protein expression gives brain-specific expression, while confocal
imaging depicts region specific (mPFC: Layer V and CA1)
expression. Although total brain MAPK/ErK did not change
at P365 (Figure 3E), mPFC and CA1 MAPK/ErK expressions
increased significantly when compared with P80 (Figures 3B,C).
Likewise, in spite of a decrease in brain MAPK/ErK at P730
(Figure 3E), hippocampal and cortical distribution of the
proteins were significantly higher than what was recorded at
P80 (Figures 3B,C). Furthermore, mPFC expression reduced
(p < 0.001; Figure 3C), while CA1 expression increased,
significantly at P730 (p < 0.001) when compared with
P365 levels.
Age-Linked Depletion of Brain CaMKIIα
Based on our hypothesis (Figure 1), an increase in the expression
of brain p-MAPK/ErK may alter synaptic CaMKIIα function
through phosphorylation (inactivation). In support of this
proposition, an increase in the percentage of brain p-MAPK/ErK
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FIGURE 2 | (A,B) Representative confocal images showing the distribution of IGF-1R hippocampus and medial prefrontal cortex (mPFC) of postnatal days 80 (P80),
P365 and P730 mice (scale bar = 20 µm). Arrow heads show the distribution of IGF-1R in Layer V vesicular GABA transporter (VGAT) positive neurons. (C) Bar chart
(One-Way analyses of variance (ANOVA)) showing a decrease in hippocampal IGF-1R expression at P365 (p < 0.001) when compared with P80 hippocampus.
There was further decline in hippocampal IGF-1R at P730 (p < 0.01) when compared with P365, and P80 (p < 0.001) hippocampus. (D) Bar chart (One-Way
ANOVA) showing a significant decrease in IGF-1R in the mPFC of P365 and P730 mice when compared with P80 (p < 0.001). No significant change was seen for
hippocampal IGF-1R expression when we compared P365 and P730 hippocampus. (E,F) Quantitative western blots showing a significant decrease in
insulin-like growth factor-1 (IGF-1) expression in total brain lysate at P730 when compared with P80 (p < 0.001) and P365 (p < 0.001). No significant change in
IGF-1 was observed at P365 when compared with P80. Protein expression per lane was normalized with GAPDH in 15 µg total protein for P80, P365 and
P730 groups. (G,H) IGF-1R expression reduced in total brain lysate at P365 (p < 0.001) when compared with P80. There was a further decrease in neural IGF-1R
expression at P730 (p < 0.001) when compared with P80 and P365. ∗∗p < 0.01, ∗∗∗p < 0.001.
was associated with a significant decrease in CA1 and mPFC
CaMKIIα expression with age (Figures 4A,B). Normalized
fluorescence intensity for immunolabeled CaMKIIα reduced
significantly in the hippocampus at P365 (p < 0.001) and P730
(p < 0.001) when compared with the control (Figure 4C).
Likewise, there was a significant reduction in prefrontal cortical
expression of CaMKIIα for P365 and P730 mice when compared
with P80 (p < 0.001; Figure 4D). The outcome for confocal
fluorescence quantification was further confirmed through
immunoblot quantification of CaMKIIα in whole brain lysate.
As such CaMKIIα expression reduced significantly in the lysate
prepared from P365 and P730 mice brains when compared with
P80 brain lysate in immunoblotting (Figures 4E,F; p < 0.001).
A further decline in brain CaMKIIα was observed at P730; when
compared with P365 CaMKIIα expression (p< 0.05; Figure 4F).
Since p-MAPK/ErK can phosphorylate synaptic CaMKIIα
(Giovannini et al., 2001; Tsui et al., 2005), we evaluated the
significance of increased p-MAPK/ErK (P730) on the normalized
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FIGURE 3 | (A) Representative confocal images showing the distribution of MAPK/ErK in the cortex (mPFC) and hippocampus (arrow heads indicates CA1) of P80.
P365 and P730 mice (scale bar = 100 µm). Arrowheads indicate the CA1 area of the hippocampus. Star signs depict the margins of the PFC. (B) Bar chart showing
an increase in hippocampal MAPK/ErK expression for P365 (p < 0.001) and P730 (p < 0.001) groups when compared with P80. (C) Bar chart showing an increase
in the expression of MAPK/ErK in the mPFC of P365 mice. MAPK/ErK expression was higher at P365 when compared with P80 (p < 0.001) and P730 (p < 0.001).
Equally, MAPK/ErK expression increased in the mPFC of P730 mice when compared with P80 (p < 0.05). (D) Immunoblots showing the expression of MAPK/ErK in
total brain lysate for P80, P365 and P730 groups. (E) Bar chart showing a decrease in normalized expression of MAPK/ErK in the brain of P730 mice.
(F–H) Quantitative immunoblots showing a change in the expression of phosphorylated MAPK/ErK at P365 and P730. Percentage p-MAPK/ErK increased
significantly in the P730 (85%; p < 0.001) group when compared with P80 (47%) and P365 (25%). ∗p < 0.05, ∗∗∗p < 0.001.
expression of p-CaMKIIα in whole brain lysate. In addition to
a decrease in CaMKIIα, P365 and P730 mice exhibited a
significant depletion of neural p-CaMKIIα when compared
with P80 expression (p < 0.001 and p < 0.05 respectively;
Figures 4G,H). CaMKIIα expression decreased significantly
in P730 brain lysate when compared with P365 expression
(p < 0.05; Figures 4E,F). Conversely, p-CaMKIIα expression
increased significantly in P730 brain when compared with
P365 expression (p < 0.01; Figures 4G,H). In subsequent
analysis, we determined percentage phosphorylation of
CaMKIIα by comparing normalized expression of CaMKIIα
and p-CaMKIIα for P80, P365 and P730 brain lysates
[p-CaMKIIα/(p-CaMKIIα+CaMKIIα) × 100] (Figure 4I).
Interestingly, there was a significant increase in percentage
phosphorylated CaMKIIα at P730 (p < 0.05) when compared
with P80 and P365 groups. Taken together, our results show
a significant decrease in total CaMKIIα (p < 0.05) at P365.
However, for P730 brain, percentage phosphorylated CaMKIIα
was upregulated in addition to a decrease in neural CaMKIIα
expression (Figures 4F–I).
Differential Expression of Small-Ion
Conductance Channels KCa2.2 in the
Hippocampus-PFC Axis
We hypothesized that CaMKIIα regulation of KCa2.2 may
be altered because of a decrease in neural CaMKIIα
expression (P356 and P730) and increased percentage of
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FIGURE 4 | (A,B) Representative confocal images showing a substantive
decrease in cortical and hippocampal CaMKIIα expression for the P365 and
P730 groups (scale bar = 100 µm). (C) Bar chart showing a significant
decrease in hippocampal CaMKIIα expression for P365 (p < 0.001) and P730
(p < 0.001) mice when compared with P80 expression level. (D) Bar chart
showing a decrease in CaMKIIα expression for the mPFC (arrow head) for
P365 (p < 0.001) and P730 mice (p < 0.001) when compared with P80.
(E,F) Quantitative western blots showing a decrease in CaMKIIα in total brain
lysate for P365 (p < 0.001) and P730 (p < 0.001) mice when compared with
the P80 group. A significant decrease was also seen between P365 and P730
(p < 0.05). (G,H) Immunoblots showing a decrease in brain p-CaMKIIα for
P365 (p < 0.001) and P730 (p < 0.05) mice when compared with
P80 p-CaMKIIα expression. An increase in p-CaMKIIα was observed when
P730 was compared with P365 (p < 0.01). (I) Percentage phosphorylated
CaMKIIα expression increased significantly at P730 (p < 0.05) when
compared with P80 and P365. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001.
phosphorylated CaMKIIα in the P730 brain (Figures 4E–I).
Moreover, in addition to increased CaMKIIα phosphorylation
by p-MAPK/ErK, the protein (i.e., p-MAPK/ErK) may
directly activate the pore forming subunit of KCa2.2
(Figure 1). Owing to a decrease in CaMKIIα expression
or an increased CaMKIIα phosphorylation, the activity
of KCa2.2 may become upregulated. Consequently, either
downregulation of CaMKIIα or an increased p-MAPK/ErK-
mediated KCa2.2 phosphorylation would lead to attenuation
of synaptic potentials. This may be related to prolonged
after-hyperpolarization currents that are linked to increased
KCa2.2 activity at synapses (K+ ion movement; Figure 1).
In KCa2.2 immunolabeled sections, we found that
KCa2.2 expression varied in the hippocampus and cortex
(Figures 5A,B). In the hippocampus, normalized fluorescence
intensity of immunolabeled KCa2.2 (expression) increased
significantly at P365 (p < 0.05) and P730 (p < 0.001) when
compared with P80 (Figure 5C). Additionally, we observed
an age-linked increase in hippocampal KCa2.2 expression
when comparing P365 with P80 (p < 0.05), and P730 vs. P365
(p < 0.01; Figure 5C). The outcome for the hippocampal
expression of IGF-1R, MAPK, CaMKIIα and KCa2.2 support
our hypothesis. As such a change in hippocampal IGF-1R
was associated with increased MAPK phosphorylation
(Figure 3B), depleted CaMKIIα (Figure 4C) and upregulated
KCa2.2 expression (Figure 5C).
Surprisingly, decreased cortical CaMKIIα (Figure 4D) and
increased MAPK/ErK (Figure 3C) was associated with reduced
KCa2.2 expression for the P365 mice (p < 0.001); when
compared with P80 mice (Figure 5D). However, there was
a significant increase in cortical KCa2.2 expression at P730
(p < 0.01) when compared with P365 expression levels.
This outcome agrees partially with our hypothesis, since the
mPFC exhibits a distinct pattern of KCa2.2 expression when
compared with the hippocampus in aged mice. In the mPFC,
CaMKIIα expression was significantly sustained at P365 when
compared with P730 (p < 0.05; Figures 4E,F). Conversely, the
expression of phosphorylated CaMKIIα was significantly lower
in P365 brain lysate when compared with P730 expression
(p < 0.01; Figures 4G,H). Pertaining to CaMKIIα regulation of
KCa2.2 function, we deduced that a decrease in cortical CaMKIIα
expression at P365 was not sufficient to cause upregulation of
KCa2.2 in the mPFC. Rather, a decreased expression together
with an increased percentage phosphorylation (inactivation) of
CaMKIIα might have contributed to upregulation of cortical
KCa2.2 at P730 (Figure 5D). Taken together, we infer
that decreased expression and increased phosphorylation of
CaMKIIαmay be associated with dysregulation of KCa2.2 in the
CA1 and mPFC.
In subsequent analysis, we found that neural KCa2.2 did not
significantly change at P365 in whole brain lysate (Figures 5E,F).
However, it is important to note that regional variations may
occur, as observed for the hippocampus and cortex through
immunohistochemical methods. As such, KCa2.2 expression
increased in the hippocampus but decreased in themPFC at P365
(Figures 5C,D) when assessed through immunohistochemistry.
At P730, there was a significant decrease in whole brain
KCa2.2 expression (Figure 5F; p< 0.001) although hippocampal
KCa2.2 (confocal) expression remained significantly higher
when compared with P80 (p < 0.001) and P365 (p < 0.01). In
order to ascertain a change in post-synaptic profile, we evaluated
Frontiers in Neuroanatomy | www.frontiersin.org 8 May 2018 | Volume 12 | Article 35
Ogundele et al. Consequence of CaMKIIα Phosphorylation in Synaptic Aging
FIGURE 5 | (A) Representative confocal images showing a KCa2.2 expression
pattern in the hippocampus (scale bar = 50 µm). (B) Confocal images
showing the cortical distribution of KCa2.2 in the PFC (scale bar = 50 µm).
(C) Bar chart depicting a statistical comparison for KCa2.2 expression in the
hippocampus. An age-dependent increase in hippocampal KCa2.2 expression
was recorded at P365 (p < 0.05) and P730 (p < 0.001) when compared with
P80. (D) Bar chart showing a significant decrease in cortical KCa2.2 for P365
(p < 0.001) and P730 mice (p < 0.01); vs. P80 expression level.
(E,F) Quantitative western blots showing a decreased KCa2.2 expression in
total brain lysate at P730 when compared with P80 or P365 (p < 0.001).
(G–I) Quantitative western blots showing a significant decrease in
post-synaptic markers in P730 total brain lysate. PSD-95 (p < 0.001) and
Homer-1 expression (p < 0.001) reduced significantly for the P730 group
when compared with P80 or P365 mice. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001.
the expression of post-synaptic structural proteins that are closely
related to synaptic function, KCa2.2 and CaMKIIα expression at
PSDs densities. In support of our results, there were significant
changes in the expression of PSD-95 and Homer1 in whole brain
lysate of aged (P730) animals when compared with P80 and
P365 expression (p< 0.001; Figures 5G–I).
Synaptic Excitatory and Inhibitory
Transport
Since IGF-1R is involved in the modulation of presynaptic
function (Gazit et al., 2016), we compared age-linked changes
in the expression of IGF-1R and presynaptic proteins associated
with vesicle and neurotransmitter transport. Furthermore,
we highlighted possible links between dysregulated IGF-
1R- CaMKIIα-KCa2.2 function and excitatory/inhibitory
neurotransmitter transporter protein expression in the
CA1 and mPFC regions. In addition to age-linked decreases
in IGF-1R, there was a significant decrease in the count of
inhibitory GABAergic and Glycinergic neurons expressing
VGAT (Figures 6A–D). In the hippocampus (CA1-DG
field), the count of VGAT-Venus neurons decreased at P365
(p < 0.001) and P730 (p < 0.001) when compared with
P80 count (Figures 6A,C). Likewise, VGAT-Venus neuron
count decreased in the mPFC of P365 and P730 mice when
compared with P80 scores (Figures 6B,D). Equally, there was
a significant loss of VGLUT2 in whole brain lysate of aged
mice (Figures 6E,F). This suggests a significant change in
presynaptic morphology; similar to changes in post-synaptic
protein expression described previously (PSD-95 and Homer1;
Figures 5G–I). Interestingly, synaptophysin, a presynaptic
protein, increased in total brain lysate at P730 when compared
with P80 (Figures 6E,F; p < 0.001) and P365 expression
(p < 0.01). Although IGF-1R is known to mediate the synaptic
activity of synaptophysin (Gazit et al., 2016), our results
suggest an inverse relationship for this interaction. As such, a
decrease in neural IGF-1R was accompanied by an increase in
synaptophysin expression. This may represent a compensatory
mechanism for the loss of synaptic function in the aging
brain. Based on these outcomes, we deduced that loss of
IGF-1R signaling in the aged brain may be linked to depletion
of post-synaptic proteins, dysregulation of IGF-R-linked
presynaptic neurotransmitter transport, and synaptophysin
activity.
DISCUSSION
The role of IGF-1 and IGF-1R have been extensively described
in the pathophysiology of age-related brain disorders and
developmental synaptic dysfunction (van Dam and Aleman,
2004; Chiu and Cline, 2010; Fernandez and Torres-Alemán,
2012; Dyer et al., 2016; Reim and Schmeisser, 2017; Wrigley
et al., 2017). The outcome of this study demonstrates that
age-related changes in IGF-1/IGF-1R activity may be associated
with dysregulated synaptic MAPK/ErK and CaMKIIα function.
We found that an age-related decrease in IGF-1/IGF-1R
expression was associated with reduction of neural CaMKIIα
expression and increased MAPK/ErK phosphorylation in the
brain. Based on our hypothesis (Figure 1), the physiological
implication of these outcome may involve increased activity
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FIGURE 6 | (A,B) Representative confocal images showing age-dependent changes in the distribution of inhibitory neurons in the hippocampus and prefrontal
cortex (PFC; scale bar = 50 µm). (C,D) Bar chart depicting a statistical change in PFC and hippocampal inhibitory neurons (VGAT-Venus) cell count. A significant
decrease in inhibitory neurons was recorded for the P365 and P730 hippocampus and cortex (p < 0.001, p < 0.001) when compared with P80. (E,F) Quantitative
immunoblots showing a significant increase in synaptophysin expression in whole brain lysate of P730 (p < 0.001) mice when compared with P80 (p < 0.001) and
P365 (p < 0.01). (G,H) Quantitative immunoblots showing a significant decrease in neural vesicular glutamate transporter 2 (VGLUT2) expression at P365 (p < 0.05)
and P730 (p < 0.001) when compared with P80 expression. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001.
of small ion conductance channels (KCa2.2) at hippocampal
PSDs, and decreased expression in the mPFC of aged mice.
Increased KCa2.2 expression in the hippocampus may occur
due to reduced CaMKIIα-dependent KCa2.2 inhibition,
increased CaMKIIα phosphorylation (inactivation) by p-
MAPK/ErK, and upregulated phosphorylation (activation) of
KCa2.2 by p-MAPK/ErK. Taken together, our results suggest
that age-linked changes in IGF-1R signaling may alter synaptic
KCa2.2 regulation by disrupting the balance of regulatory
synaptic proteins, CaMKIIα and MAPK/ErK.
IGF-1/IGF-1R-Linked Alteration in Synaptic
Kinases
IGF-1R is activated by endogenous IGF-1 (Dyer et al., 2016;
Gazit et al., 2016). This interaction contributes to the regulation
of presynaptic Ca2+ signaling and Ca2+ release from the
mitochondria (Gazit et al., 2016), N-type, and L-type calcium
channels (Blair and Marshall, 1997). Although, synaptic function
(LTP) involves a synchronous oscillation of Ca2+ and K+ ions
(Bacci et al., 1999; Power et al., 2002), the effect of IGF-1/IGF-
1R signaling on the activity of calcium-dependent potassium
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channels (KCa2.2) is poorly understood. Furthermore, how an
age-dependent change in IGF-1/IGF-1R signaling contributes
to dysregulation of synaptic KCa2.2 function in the aged brain
has yet to be investigated. In this study, we described some
of the possible pathways through which a change in IGF-1R
signaling can alter synaptic KCa2.2 activity in the aging cortex
and hippocampus.
Alterations in Synaptic Kinases and
KCa2.2 Expression
Our results indicate that a decrease in IGF-1 and IGF-1R
with age was associated with a significant change in the
expression and phosphorylation of synaptic kinases involved in
synaptic function. Hippocampal and prefrontal cortical IGF-1R
expression decreased by middle age as seen in P365 mice
(Figures 2C,D). However, depletion of brain IGF-1 occurred
much later in P730 brain lysate (Figures 2G,H). To test our
hypothesis, we evaluated the significance of age-linked IGF-
1/IGF-1R alteration on the relative expression ofMAPK/ErK and
CaMKIIα in the hippocampus and mPFC of mice. In addition to
acting downstream of IGF-1R (Chiu and Cline, 2010; Deak and
Sonntag, 2012; Dyer et al., 2016), both proteins (i.e., MAPK/ErK
and CaMKIIα) are involved in the regulation of neurotransmitter
receptors and ion channels at synapses (Giovannini et al., 2001;
Tsui et al., 2005). Moreover, previous studies have described
co-localization of MAPK/ErK and CaMKIIα at post-synaptic
sites (Giovannini et al., 2001; Tsui et al., 2005; Hammond
et al., 2006). Since IGF-1R regulates MAPK/ErK and CaMKIIα
through the Ras/Raf/ErK pathway, a change in IGF-1R signaling
may alter the synaptic activity of MAPK/ErK and CaMKIIα. In
aging, a decline in IGF-1R may cause an increase in MAPK
phosphorylation. Thus, an increase in activated p-MAPK/ErK,
can facilitate phosphorylation (inactivation) of CaMKIIα thereby
disrupting synaptic function (Ferrer et al., 2001; Giovannini et al.,
2001; Hoofnagle et al., 2004).
Age-dependent changes in IGF-1/IGF-1R are associated
with dysregulation of MAPK/ErK and CaMKIIα expression
(Figures 3, 4). MAPK/ErK and CaMKIIα modulates NMDAR-
linked calcium currents (Hinds et al., 2003; Mao et al., 2014)
and calcium-activated potassium channels (KCa2.2) during LTP
(Giovannini et al., 2001; Hammond et al., 2006; Lin et al., 2010).
Therefore, we examined the differential expression of KCa2.2 in
the hippocampus and cortex of aged mice, characterized by
a decrease in IGF-1/IGF-1R and altered MAPK/CaMKIIα
expression (Figure 5). Our results show that an increase in
p-MAPK/ErK, and decreased CaMKIIα was associated with
upregulated KCa2.2 expression in the hippocampus of aged
mice. Although previous studies show a change in Ca2+ currents
relative to IGF-1R function (Blair and Marshall, 1997; Gazit
et al., 2016), here we propose a possible mechanism through
which IGF-1R might alter K+ current through the regulation of
substrates that modulate synaptic KCa2.2 function in aging.
The physiological implication of increased neural
KCa2.2 activity has been described previously by Hammond et al.
(2006). They demonstrate that an increase in KCa2.2 activity
abolishes synaptic potentials and reduced memory function in
mice (Hammond et al., 2006; Maingret et al., 2008; Lin et al.,
2010). In separate studies, changes in the expression of KCa2.2 in
young mice precipitated a decline in memory formation
and retrieval (Stackman et al., 2002; Hammond et al., 2006).
Evidently, the expression and activity of KCa2.2 represents a
crucial part of synaptic regulation and LTP (Disterhoft and
Oh, 2006, 2007). Expression of KCa2.2 and other post-synaptic
proteins—PSD-95 and Homer1–show significant declines with
age in the brain. Thus, differential hippocampal and cortical
KCa2.2 expression suggest adaptive physiological changes
in normal synaptic aging. Our results suggest that decreased
CaMKIIα, increased CaMKIIα phosphorylation, and increased
MAPK/ErK phosphorylation are possible causes of synaptic
KCa2.2 dysregulation that may be linked to decreased IGF-1R
signaling in the normal aging brain.
Neurotransmission
In addition to a change in KCa2.2 expression and post-synaptic
proteins (Homer1 and PSD-95), we found a significant change in
presynaptic protein expression in the aged brain. While previous
studies have shown the role of IGF-1R in the presynaptic
activity of synaptophysin (Gazit et al., 2016), here we showed
an inverse relationship between IGF-1R and synaptophysin
expression in the aged (P730) brain. Our results indicate
that a decrease in IGF-1R was associated with a significant
increase in synaptophysin expression with age (Figures 6G,H).
Conversely, there was a decrease in the expression of Venus in
VGAT-positive puncta (confocal) and VGLUT2 (immunoblots)
in the brain of aged mice (P730). From these outcomes, we
deduced that an increased p-MAPK/ErK can increase the activity
of synaptophysin independent of neurotransmitter transport.
Yokomaku et al. (2003) support this proposition by showing that
MAPK signaling inhibitors suppressed synaptophysin function
in cultured neurons. Synaptophysin expression and activity
were rescued by estradiol-mediated MAPK/ErK increase in vitro
(Yokomaku et al., 2003). Since VGAT and VGLUT2 exist
in the presynaptic area (Zander et al., 2010), it is logical to
speculate that a change in CaMKIIα control of KCa2.2 function
may alter the synaptic expression and activity of VGAT and
VGLUT2 (Trimmer, 2015), although the mechanism remains
to be resolved. As such, selective activation of IGF-1R and
inhibition of KCa2.2 function are possible intervention methods
for attenuating CaMKIIα loss and synaptic dysfunction in
aging.
CONCLUSION
Taken together, the outcome of this study showed that
neural IGF-1/IGF-1R expression is reduced with age in the
hippocampus and cortex. IGF-1/IGF-1R depletion is linked to
increased neural MAPK/ErK phosphorylation and CaMKIIα
depletion in the aged brain. We showed that loss of IGF-1/IGF-
1R was also associated with a change in the synaptic expression of
KCa2.2; especially in the hippocampus of aged mice. Ultimately,
this might lead to a decline in presynaptic neurotransmitter
function and loss of post-synaptic proteins.
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